NKGN OTC
NKGen Biotech, Inc.
1W: -8.3%
1M: +10.0%
3M: -81.7%
YTD: -78.0%
1Y: -90.0%
$0.01
-0.00 (-8.33%)
Weekly Expected Move ±255.5%
$-0
$-0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+100.0% ▲
Operating Income
-$27M
+9.3% ▲
Net Income
-$44M
+46.6% ▲
EPS (Diluted)
$-1.54
+71.4% ▲
EBITDA
-$27M
+5.5% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|
| Revenue | $426K | $77K | $0 | $0 |
| YoY Growth | +0.0% | -81.9% | -100.0% | +0.0% |
| Cost of Revenue | $30K | $18K | $1M | $0 |
| Gross Profit | $396K | $59K | -$1M | $0 |
| Gross Margin | 93.0% | 76.6% | — | — |
| R&D Expenses | $15M | $17M | $14M | $11M |
| SG&A Expenses | $8M | $8M | $14M | $16M |
| Operating Expenses | $22M | $24M | $29M | $27M |
| Operating Income | -$22M | -$24M | -$30M | -$27M |
| Operating Margin | -5131.7% | -31618.2% | — | — |
| Interest Expense | $1M | $2M | $745K | $3M |
| Income Before Tax | -$23M | -$27M | -$83M | -$44M |
| Tax Expense | $5K | $7K | $7K | $53K |
| Net Income | -$23M | -$27M | -$83M | -$44M |
| Net Margin | -5461.3% | -34745.5% | — | — |
| EPS (Diluted) | $-1.08 | $-1.25 | $-5.38 | $-1.54 |
| EBITDA | -$21M | -$23M | -$81M | -$27M |
| Shares Outstanding | 21M | 21M | 15M | 29M |